Education
About Us
Working with TipRanks
Follow Us
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
Tarsus Pharmaceuticals (TARS) Ownership Overview
3.22% Insiders
20.13% Mutual Funds
55.84% Other Institutional Investors
12.56% ETFs
8.25% Public Companies and
Individual Investors
The ownership structure of Tarsus Pharmaceuticals (TARS) stock is a mix of institutional, retail, and individual investors. Approximately 88.53% of the company’s stock is owned by Institutional Investors, 3.22% is owned by Insiders, and 8.25% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 10, 2025 | xxxxxxxxxxxxx | $1545612 | |
Mar 20, 2025 | xxxxxxxxxxxxx | $1163050 | |
Mar 20, 2025 | xxxxxxxxxxxxx | $178306 | |
Mar 20, 2025 | xxxxxxxxxxxxx | $505856 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2025 | xxxxxxxxxxxxx | $1872045 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,931,193 | Institution | 4.55% | 140,822,594 | |
| 1,873,907 | Institution | 4.41% | 136,645,298 | |
| 1,811,228 | Institution | 4.27% | 132,074,746 | |
| 1,031,041 | Institution | 2.43% | 75,183,510 | |
| 865,741 | Insider | 2.04% | 63,129,834 | |
| 854,389 | Institution | 2.01% | 62,302,046 | |
| 684,050 | Institution | 1.61% | 49,880,926 | |
| 680,797 | Institution | 1.60% | 49,643,717 | |
| 424,515 | Institution | 1.00% | 30,955,634 | |
| 406,248 | Institution | 0.96% | 29,623,604 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,811,228 | Institution | 4.27% | 132,074,746 | |
| 854,389 | Institution | 2.01% | 62,302,046 | |
| 680,797 | Institution | 1.60% | 49,643,717 | |
| 424,515 | Institution | 1.00% | 30,955,634 | |
| 406,248 | Institution | 0.96% | 29,623,604 | |
| 387,589 | Institution | 0.91% | 28,262,990 | |
| 382,765 | Institution | 0.90% | 27,911,224 | |
| 358,364 | Institution | 0.84% | 26,131,903 | |
| 344,660 | Institution | 0.81% | 25,132,607 | |
| 330,960 | Institution | 0.78% | 24,133,603 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,195,227 | Institution | 2.82% | 71,032,341 | |
| 955,249 | Institution | 2.25% | 69,284,210 | |
| 413,276 | Institution | 0.97% | 24,560,993 | |
| 342,793 | Institution | 0.81% | 24,862,776 | |
| 252,091 | Institution | 0.59% | 18,382,476 | |
| 187,026 | Institution | 0.44% | 13,564,996 | |
| 186,542 | Institution | 0.44% | 11,086,191 | |
| 123,704 | Institution | 0.29% | 8,972,251 | |
| 123,704 | Institution | 0.29% | 8,972,251 | |
| 123,704 | Institution | 0.29% | 8,972,251 |
FAQ
Who Owns Tarsus Pharmaceuticals (TARS)?
According to the latest TipRanks data, approximately 55.84% of the company's stock is held by institutional investors, 3.22% is held by insiders, and 8.25% is held by retail investors.
What percentage of Tarsus Pharmaceuticals (TARS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 55.84% of Tarsus Pharmaceuticals (TARS) stock is held by institutional investors.
What percentage of Tarsus Pharmaceuticals (TARS) stock is held by retail investors?
According to the latest TipRanks data, approximately 8.25% of Tarsus Pharmaceuticals (TARS) stock is held by retail investors.
Who owns the most shares of Tarsus Pharmaceuticals (TARS)?
Vanguard owns the most shares of Tarsus Pharmaceuticals (TARS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.